Ticker Symbol: KRYS
Krystal Biotech Inc
$48.62 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001711279
Company Profile
krystal biotech, inc. is using gene therapy to develop effective and novel treatments for skin diseases. our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases. we work to accomplish that through scientific innovation, operational excellence and believe that “nature operates in the shortest way possible”. (aristotle)
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 2100 Wharton St Ste 701
Website: https://www.krystalbio.com/
CEO: Krish S. Krishnan
Tags:
- Health Technology
- Pharmaceuticals: Major
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $111.99
Change:
$0.42
(
0.38%)
Days Range: $110.11 - $112.66
Beta: 0.70
52wk. High: $132.68
52wk. Low: $66.20
Ytd. Change 41.21%
50 Day Moving Average: $117.52
200 Day Moving Average: $112.50
Shares Outstanding: 27994177
Valuation
Market Cap: 313.5B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A